[Congressional Record Volume 163, Number 169 (Thursday, October 19, 2017)]
[Senate]
[Page S6700]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1567. Ms. KLOBUCHAR submitted an amendment intended to be proposed 
to amendment SA 1116 proposed by Mr. Enzi to the concurrent resolution 
H. Con. Res. 71, establishing the congressional budget for the United 
States Government for fiscal year 2018 and setting forth the 
appropriate budgetary levels for fiscal years 2019 through 2027; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING 
                   PRESCRIPTION DRUG PRICES BY LIFTING THE BAN ON 
                   MEDICARE NEGOTIATING PART D PRESCRIPTION DRUG 
                   PRICES.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     lowering prescription drug prices by lifting the ban that 
     makes it illegal for Medicare to negotiate prescription drug 
     prices on behalf of millions of seniors by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2018 through 
     2022 or the period of the total of fiscal years 2018 through 
     2027.
                                 ______